Yahoo Web Search

Search results

  1. What’s the outlook for synovial sarcoma? The five-year survival rate for synovial sarcoma is 50% to 60%. That means that 5 to 6 out of 10 people with synovial sarcoma are still alive five years after their diagnosis. The five-year metastasis-free survival rate is 40% to 60%.

  2. Aug 23, 2016 · The first surgery to remove a synovial sarcoma tumor may determine a patients prognosis. If the diagnosis was made after the tumor was removed, make sure the doctors got all the cancer out. If you’re still not confident, get a second opinion.

    • Devon Carter
  3. Jun 7, 2021 · Sarcoma prognosis is unique to the individual's medical history, type of sarcoma, stage of cancer at diagnosis, and response to treatment. Learn how sarcoma survival rate and treatment varies by stage, including survival rate for stage 4 sarcoma (sarcoma with metastasis).

    • Lorna Collier
    • Contributor
  4. Apr 27, 2023 · Surgery is the main treatment for synovial sarcoma. The goal is to remove the cancer and some of the healthy tissue around it. This can sometimes mean the removal of an entire muscle or muscle group. In the past, surgery might have included removing an arm or leg, known as amputation.

  5. Mar 7, 2018 · Synovial sarcoma (SS) is a rare, yet highly malignant, type of soft tissue sarcoma (STS), for which survival has not improved significantly during the past years. In this review, we focus on systemic treatment in adults.

    • Ingrid M. E. Desar, Emmy D. G. Fleuren, Winette T. A. van der Graaf
    • 2018
  6. Aug 23, 2023 · The 5-year cancer-specific survival (CSS) rates are ∼60% in adults and 80% in younger patients. 19 Compared with those presenting with localized disease, patients with advanced SS at initial diagnosis have a poor prognosis. 23 Adults with metastatic SS at diagnosis have a 5-year overall survival (OS) rate of 10% versus 76% for those with ...

  7. People also ask

  8. Feb 2, 2017 · Survival rates are grouped based on how far the cancer has spread, but your age, overall health, tumor grade, location where the tumor started (arm, leg, or retroperitoneum), how well the cancer responds to treatment, and other factors can also affect your outlook.